Alexander Semenov joined the Board of the Association of Pharmaceutical Manufacturers of the EAEU
The company Acticomp joined the Association of Pharmaceutical Manufacturers of the EAEU several years ago and has been an active member of the Association since then. At the moment, Acticomp is the only member of the association that specializes in developing and producing active pharmaceutical ingredients, and the company is also responsible for the work of the Association in this direction.
Currently, the issue of reducing dependence on imports of pharmaceutical raw materials is one of the key issues for the members of the Association and the industry as a whole. The main task facing the Association is the development of joint decisions with the state aimed at stimulating investments when expanding local production of active pharmaceutical ingredients, both in terms of meeting domestic demand and export development.
Stanislav Naumov, Chairman of the Board of the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union (EAEU): "One of the key areas of the Association's work is the development of full-cycle pharmaceutical production. The company Acticomp occupies a leading position in the API market and has the appropriate expertise, which is shared within the framework of the Association."
Alexander Semenov, President of Acticomp: "Over the past year, the Association has reached a completely new level of interaction with government authorities on issues important to us within the industry. We can see the results of this work and promising areas of cooperation for the benefit of business, government and society. Together, we must achieve full technological sovereignty of the pharmaceutical industry, starting from its foundation – the production of active pharmaceutical ingredients (APIs)."
At this stage, the Association of Pharmaceutical Manufacturers of the EAEU has completed the procedure of forming the Board.
The final composition of the board includes: General Director of Pharmstandard JSC Grigory Potapov, President of BIOCAD Dmitry Morozov, Head of Geropharm Group Petr Rodionov, General Director of Generium JSC Dmitry Kudlai, Chairman of the Board of Directors of ChemRar Group Andrei Ivaschenko, President of Nanolek LLC Vladimir Khristenko, and the General Director of the Scientific and technological pharmaceutical company POLISAN Alexander Borisov.
The Association of Pharmaceutical Manufacturers of the Eurasian Economic Union (EAEU) was registered in 2012 and includes the leading full-cycle pharmaceutical companies: Pharmstandard JSC, Biocad JSC, Geropharm Group, Nanolek LLC, Polisan LLC, Acticomp JSC, Generium JSC, HTC ChemRar and Nativita JLLC
The purpose of the Association is to coordinate the entrepreneurial activities of the members of the Association – the pharmaceutical manufacturers of the Eurasian Economic Union engaged in the production of drugs, as well as to protect and represent the common interests of the members of the Association, including:
- assisting Association members in achieving compliance with the rules of good manufacturing practice (GMP);
- assistance in providing medicines to the population and medical-preventive institutions, as well as developing the pharmaceutical market of EAEU member states;
- promotion of scientific research in the field of drug circulation